EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Percutaneous Image-Guided Non-Target Renal Biopsy in Cancer Patients: A Tertiary Cancer Center Experience

Mohamed E Abdelsalam iD, Milan N Patel, Ryan D Murray, Shahroz Khalid Aziz, Haley Shields, Pamela Chien, Steven Yevich, Zeyad A Metwalli, Zhongya Wang, Jamie S Lin, Steven Y Huang iD, David Irwin und 7 weitere

Current Oncology · 30.03.2026 · 33 (4) · 192

DOI: 10.3390/curroncol33040192 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Oncology, online erschienen am 30.03.2026. Verfasst von Mohamed E Abdelsalam und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Hauptthemen laut MEDLINE: Image-Guided Biopsy, Kidney, Kidney Neoplasms, Neoplasms. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To assess the safety and diagnostic outcomes of image-guided, non-target renal biopsies performed in cancer patients. Materials and Methods: We retrospectively identified patients who underwent percutaneous, image-guided, non-target renal biopsy between January 2017 and December 2020 in our institution. We recorded demographics, clinical, procedural, and pathologic details. Univariate and multivariable logistic regression models were used to assess the association between various variables and diagnostic yield or development of adverse events.

Results

A total of 318 biopsies were performed in 318 patients (178 male, 140 female) with a median BMI of 28.4 kg/m2. Median systolic and diastolic BP at the time of biopsy were 133 mmHg and 74 mmHg, respectively. Tissue was obtained using 18-gauge needles (99%). Adverse events were documented in 57 cases (18%), with 12 cases (3.8%) classified as grade 2 or higher per SIR classification. Diagnosis was achieved in 310 biopsies (97%). The median number of the glomeruli identified by light microscopy, immunofluorescence, and electron microscopy was 25, 8, and 3, respectively, and a higher number of identified glomeruli was associated with diagnostic yield in univariate analysis, although not in multivariable analysis. Diastolic BP higher than 80 mmHg and CT imaging guidance were associated with the development of adverse events in univariate analysis, and CT use remained so in the final multivariable analysis (p < 0.001). No other variables, including pre-biopsy anticancer or immunotherapy medications, were associated with increased risk of adverse events.

Conclusions

Percutaneous, image-guided, non-target renal biopsy in cancer patients using an 18-gauge needle has a high diagnostic yield and safety profile.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Image-Guided BiopsyKidneyKidney NeoplasmsNeoplasmsHumansFemaleMaleMiddle AgedRetrospective StudiesAgedTertiary Care CentersAdult

Stichwörter der Autor:innen

biopsycancernephropathynon-targetrenal

Autor:innen und Institutionen

  • Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Department of Radiology, Keck School of Medicine, University of South California, Los Angeles, CA 90033, USA.
  • Department of Radiology, The University of Texas McGovern Medical School, Houston, TX 77030, USA.
  • Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Department of Internal Medicine, Section of Nephrology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

ORCID-Profile: Mohamed E Abdelsalam, Steven Y Huang, Stephen R Lee, Ala Abudayyeh, Bruno C Odisio

Zitieren

APA

Abdelsalam, M. E., Patel, M. N., Murray, R. D., Aziz, S. K., Shields, H., Chien, P., Yevich, S., Metwalli, Z. A., Wang, Z., Lin, J. S., Huang, S. Y., Irwin, D., Lu, T., Lee, S. R., Abudayyeh, A., Habibollahi, P., Odisio, B. C., Ahrar, K., & Gupta, S. (2026). Percutaneous Image-Guided Non-Target Renal Biopsy in Cancer Patients: A Tertiary Cancer Center Experience. Current Oncology, 33(4), 192. https://doi.org/10.3390/curroncol33040192

Vancouver

Abdelsalam ME, Patel MN, Murray RD, Aziz SK, Shields H, Chien P, et al. Percutaneous Image-Guided Non-Target Renal Biopsy in Cancer Patients: A Tertiary Cancer Center Experience. Current Oncology. 2026;33(4):192. doi:10.3390/curroncol33040192

BibTeX
@article{Abdelsalam2026,
  author = {Abdelsalam, Mohamed E and Patel, Milan N and Murray, Ryan D and Aziz, Shahroz Khalid and Shields, Haley and Chien, Pamela and Yevich, Steven and Metwalli, Zeyad A and Wang, Zhongya and Lin, Jamie S and Huang, Steven Y and Irwin, David and Lu, Thomas and Lee, Stephen R and Abudayyeh, Ala and Habibollahi, Peiman and Odisio, Bruno C and Ahrar, Kamran and Gupta, Sanjay},
  title = {Percutaneous Image-Guided Non-Target Renal Biopsy in Cancer Patients: A Tertiary Cancer Center Experience},
  journal = {Current Oncology},
  year = {2026},
  volume = {33},
  number = {4},
  pages = {192},
  doi = {10.3390/curroncol33040192}
}
Kostenlos starten →